The Kasumi-1 cell line: a t(8;21)-kit mutant model for acute myeloid leukemia
about
P1343
FTY720 induces apoptosis of M2 subtype acute myeloid leukemia cells by targeting sphingolipid metabolism and increasing endogenous ceramide levelsRadotinib Induces Apoptosis of CD11b+ Cells Differentiated from Acute Myeloid Leukemia CellsNational Cancer Institute pediatric preclinical testing program: model description for in vitro cytotoxicity testingEngagement of SIRPα inhibits growth and induces programmed cell death in acute myeloid leukemia cells.Comparison of plasmid DNA versus PCR amplified gene of insert DNA for nucleofection in Kasumi-1 cells.Isolation and characterization of CD34+ blast-derived exosomes in acute myeloid leukemia.Potent activity of ponatinib (AP24534) in models of FLT3-driven acute myeloid leukemia and other hematologic malignanciesABT-869, a multitargeted receptor tyrosine kinase inhibitor: inhibition of FLT3 phosphorylation and signaling in acute myeloid leukemia.Testing of the Akt/PKB inhibitor MK-2206 by the Pediatric Preclinical Testing Program.Dystroglycan Depletion Impairs Actin-Dependent Functions of Differentiated Kasumi-1 CellsRegulation of AKT signaling by Id1 controls t(8;21) leukemia initiation and progression.Cytokines in the differentiation therapy of leukemia: from laboratory investigations to clinical applications.Phosphoinositide 3-kinase/Akt signaling pathway and its therapeutical implications for human acute myeloid leukemia.UBASH3B/Sts-1-CBL axis regulates myeloid proliferation in human preleukemia induced by AML1-ETO.High-Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML.Histone H4 N-terminal acetylation in Kasumi-1 cells treated with depsipeptide determined by acetic acid-urea polyacrylamide gel electrophoresis, amino acid coded mass tagging, and mass spectrometry.Valproic acid inhibits tumor angiogenesis in mice transplanted with Kasumi‑1 leukemia cells.CD72 regulates the growth of KIT-mutated leukemia cell line Kasumi-1.Perifosine--a new option in treatment of acute myeloid leukemia?Cohesin regulates MHC class II genes through interactions with MHC class II insulators.ZGDHu-1 induces G₂/M phase arrest and apoptosis in Kasumi-1 cells.Silencing AML1-ETO gene expression leads to simultaneous activation of both pro-apoptotic and proliferation signaling.Targeted next generation sequencing of clinically significant gene mutations and translocations in leukemia.Description of a novel Janus kinase 3 P132A mutation in acute megakaryoblastic leukemia and demonstration of previously reported Janus kinase 3 mutations in normal subjects.MicroRNA-193a represses c-kit expression and functions as a methylation-silenced tumor suppressor in acute myeloid leukemia.Molecular profiling reveals myeloid leukemia cell lines to be faithful model systems characterized by distinct genomic aberrations.Drug conjugated nanoparticles activated by cancer cell specific mRNA.The Oncogenic Transcription Factor RUNX1/ETO Corrupts Cell Cycle Regulation to Drive Leukemic Transformation
P2860
Q28541065-5B222B62-2759-4F0D-9B99-64A562806F6FQ28548235-C41B92FB-2156-473E-A432-F36337A12C16Q34422537-B40C48C7-3623-44EE-87D4-7285B1696F49Q34548156-C1275C7A-6558-476B-9B93-FDA3EE36DA9BQ35085923-AC969308-5312-49B2-B825-512F8B9337EEQ35219383-19BE17B3-537A-4503-AB24-0D1FD7D98499Q35608465-E5797098-8D70-4549-9886-C0D3C5B11124Q35751114-270E8EED-8058-4CDA-8714-581ECDAD36B4Q35791105-47F44CD1-1C81-4F23-8368-F94B3390DF80Q35858815-C89F69D9-A12D-4D0F-BEF2-8529EC15F64CQ35904946-2505A484-BA2D-43ED-AC2F-B8345691CF0CQ36359510-DF5400E8-D255-4721-BBB2-EDAC96FAB831Q36461618-BAC068E7-E9FE-4C86-8ED3-8FF5DC0C0C2FQ36642902-53F6B5B3-BBA7-4B1F-9795-1D9AEC7A8137Q37200775-DFF37BDE-7773-4953-BF84-648D14888933Q37382318-D5B3E3CA-7800-4FD7-8F22-0D7BDF4BD1FAQ37496300-EB94AF59-C004-4681-8D8E-3A05497F56A0Q37693415-68697173-904A-4EB5-B24D-AA95BC92A7B2Q38127844-64D080BE-C581-4BF6-9362-73E9EA4C0D79Q38331939-6463E26F-82E3-4E34-AE90-1505F1A4261FQ38921796-DED1ACBD-9E44-4C6F-85CE-64BF850AC1D2Q39004686-77C3D7AF-8E1E-4ADA-AB51-1229BE786333Q39378248-94AFAE18-3C88-4C76-B82B-1465D3CD5E89Q39539195-8EEDB634-06C8-459D-A791-9E02B233BD7FQ39576930-0C477EE0-CC63-46C8-96E6-EFF788087B27Q40276097-AD09E9AC-1C49-4B5A-B42E-09ACA68E3016Q42363695-575EEC64-AE5D-43C1-9F90-0AD79EB8C63FQ57293716-1FCEFB0A-1C45-459A-A3A0-ADE232DB2884
P2860
The Kasumi-1 cell line: a t(8;21)-kit mutant model for acute myeloid leukemia
description
2005 nî lūn-bûn
@nan
2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
The Kasumi-1 cell line: a t(8;21)-kit mutant model for acute myeloid leukemia
@ast
The Kasumi-1 cell line: a t(8;21)-kit mutant model for acute myeloid leukemia
@en
The Kasumi-1 cell line: a t(8;21)-kit mutant model for acute myeloid leukemia
@nl
type
label
The Kasumi-1 cell line: a t(8;21)-kit mutant model for acute myeloid leukemia
@ast
The Kasumi-1 cell line: a t(8;21)-kit mutant model for acute myeloid leukemia
@en
The Kasumi-1 cell line: a t(8;21)-kit mutant model for acute myeloid leukemia
@nl
prefLabel
The Kasumi-1 cell line: a t(8;21)-kit mutant model for acute myeloid leukemia
@ast
The Kasumi-1 cell line: a t(8;21)-kit mutant model for acute myeloid leukemia
@en
The Kasumi-1 cell line: a t(8;21)-kit mutant model for acute myeloid leukemia
@nl
P2860
P3181
P1433
P1476
The Kasumi-1 cell line: a t(8;21)-kit mutant model for acute myeloid leukemia
@en
P2093
Ivana Magnani
Lidia Larizza
P2860
P304
P3181
P356
10.1080/10428190400007565
P407
P4510
P577
2005-02-01T00:00:00Z